# DESCRIPTION

## TECHNICAL FIELD

- introduce tooth agenesis treatment

## BACKGROUND ART

- summarize tooth agenesis causes and limitations

## SUMMARY OF INVENTION

### Problem to be Solved by Invention

- identify tooth agenesis treatment problem

### Solution for Problem

- introduce neutralizing antibody targeting USAG-1
- describe antibody's effect on tooth regeneration
- list antibody's characteristics
- outline pharmaceutical composition

### Effects of the Invention

- highlight clinical application of invention

## MODE FOR CARRYING OUT THE INVENTION

- motivate USAG-1 as BMP and Wnt antagonist
- describe tooth agenesis model mice and recovery of tooth formation
- produce and characterize anti-USAG-1 neutralizing antibodies
- determine neutralizing activity of antibodies
- specify antibody sequences and mutants
- define antibody A
- define antibody A mutant
- define antibody B
- define antibody B mutant
- describe antibody A properties
- describe antibody B properties
- define antibody B
- define antibody B mutant
- define antibody B variant
- define antibody C
- define antibody C mutant
- define antibody C variant
- define antibody C
- define antibody C mutant
- define antibody D
- define antibody D mutant
- describe antibody C variations
- describe antibody D variations
- define antibody D
- define antibody D mutant
- define antibody E
- define antibody E mutant
- describe antibody D variations
- describe antibody E variations
- define antibody E
- specify heavy chain complementarity determining regions
- specify light chain complementarity determining regions
- describe variable regions
- provide sequence identity percentages
- define conservative substitution
- define antibody or antigen-binding fragment
- describe epitope and binding properties
- explain competition and epitope binning
- detail antibody characteristics and production
- outline pharmaceutical composition and administration
- describe dental regeneration therapy and method

### Example 1

- prepare mouse USAG-1 neutralizing antibodies
- characterize neutralizing activity

### Example 2

- test antibody in vitro

### Example 3

- test antibody in vivo

### Example 4

- test antibody in vivo

### Example 5

- test antibody mixture in vivo

### Example 6

- confirm human USAG-1 recognition by antibody

### Example 7

- prepare additional mouse USAG-1 neutralizing antibodies

### Example 8

- perform epitope binning

### Example 9

- epitope mapping of E37 antibody
- peptide library preparation
- peptide array binding assay
- identify epitope sequence
- determine binding specificity
- summarize epitope mapping results

## INDUSTRIAL APPLICABILITY

- application of antibody

